EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomics Guided Engineering of Exosome‐Encapsulated Bifunctional Nanosheets Targeting the Immune‐PI3K/Akt Axis for Osteoporosis Therapy

Rongze Tang, Guanhong Liu, Congcong Wang, Minghao Chao, Guangyu Ma, Pengjin Wei, Siling Du, Junjie Li, Yufan Liu, Chaonan Jing, Guoquan Wu, Ming Guan und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202511327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Rongze Tang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Osteoporosis, Exosomes, Nanoparticle Drug Delivery System, Nanostructures. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province, Aired Assistance Scientific Research Project by the Affiliated Hospital of Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis, characterized by imbalanced bone metabolism and chronic inflammation, remains a therapeutic challenge due to the limitations of current single‐target therapies. This study integrates transcriptomic insights with nanomaterial engineering to develop a multi‐target strategy. Transcriptomic analysis of ovariectomized (OVX) mice reveals immune dysregulation and PI3K/Akt pathway activation, driving osteoclastogenesis. To address this, cobalt‐aluminum layered double hydroxide nanosheets (f‑CA(OH)) are synthesized, which scavenge reactive oxygen species (ROS) via peroxidase‐like activity and stabilize hypoxia‐inducible factor 1α (HIF‑1α) to upregulate BMP2 expression. Co‐culturing f‑CA(OH) with mesenchymal stem cells (MSCs) generate engineered exosomes (fCA‑BExo), encapsulating BMP2 and nanomaterials. In vitro, fCA‑BExo suppress osteoclast differentiation by blocking PI3K/Akt signaling and enhance osteogenesis via SMAD2/RUNX2 activation. In vivo, fCA‑BExo restored trabecular architecture in OVX mice, reduces pro‐inflammatory cytokines, and promote M2 macrophage polarization, demonstrating biocompatibility and efficacy. This “immune‐PI3K/Akt axis” targeting strategy offers a novel paradigm for osteoporosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisExosomesNanoparticle Drug Delivery SystemNanostructuresBone Morphogenetic Protein 2FemaleAnimalsMiceGene Expression ProfilingOvariectomyRAW 264.7 CellsPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktCoculture TechniquesBone MarrowMesenchymal Stem CellsCell EngineeringCore Binding Factor Alpha 1 SubunitSmad2 Protein

Stichwörter der Autor:innen

bone regenerationinflammationnanosheetosteoporosis

Substanzen

Nanoparticle Drug Delivery SystemPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktBmp2 protein, mouseBone Morphogenetic Protein 2Smad2 protein, mouseRunx2 protein, mouseCore Binding Factor Alpha 1 SubunitSmad2 Protein

Autor:innen und Institutionen

  • Department of Orthopedics, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221004, China.
  • Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221004, China.
  • Department of Orthopedics, The Affiliated Huai'an Hospital of Xuzhou Medical University, The Second People's Hospital of Huai'an, Huai'an, 223002, China.
  • Department of Orthopaedic Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, China.
  • Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China.

ORCID-Profile: Fenglei Gao

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangsu Province
  • Aired Assistance Scientific Research Project by the Affiliated Hospital of Xuzhou Medical University
  • The Xuzhou Medical Key Talent Training Project
  • Xuzhou Science and Technology Plan Project
  • the Graduate Research and Innovation Projects of Jiangsu Province
  • the National Natural Science Foundation of China
  • the QingLan Research Project of Jiangsu Province

Zitieren

APA

Tang, R., Liu, G., Wang, C., Chao, M., Ma, G., Wei, P., Du, S., Li, J., Liu, Y., Jing, C., Wu, G., Guan, M., Chen, H., & Gao, F. (2025). Transcriptomics Guided Engineering of Exosome‐Encapsulated Bifunctional Nanosheets Targeting the Immune‐PI3K/Akt Axis for Osteoporosis Therapy. Advanced Science. https://doi.org/10.1002/advs.202511327

Vancouver

Tang R, Liu G, Wang C, Chao M, Ma G, Wei P, et al. Transcriptomics Guided Engineering of Exosome‐Encapsulated Bifunctional Nanosheets Targeting the Immune‐PI3K/Akt Axis for Osteoporosis Therapy. Advanced Science. 2025. doi:10.1002/advs.202511327

BibTeX
@article{Tang2025,
  author = {Tang, Rongze and Liu, Guanhong and Wang, Congcong and Chao, Minghao and Ma, Guangyu and Wei, Pengjin and Du, Siling and Li, Junjie and Liu, Yufan and Jing, Chaonan and Wu, Guoquan and Guan, Ming and Chen, Hongliang and Gao, Fenglei},
  title = {Transcriptomics Guided Engineering of Exosome‐Encapsulated Bifunctional Nanosheets Targeting the Immune‐PI3K/Akt Axis for Osteoporosis Therapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202511327}
}
Kostenlos starten →